Veerle Compernolle
Overview
Explore the profile of Veerle Compernolle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1707
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Aelst B, Bens K, Sabot B, Vertongen S, Feys H, Compernolle V, et al.
Transfus Med Hemother
. 2024 Dec;
51(6):424-429.
PMID: 39664461
Introduction: Platelet additive solutions support ex vivo storage of platelet concentrates used for transfusion. The composition of platelet additive solutions within one generation (i.e., PAS-E) is similar but not identical....
2.
Delabie W, De Bleser D, Vandewalle V, De Prest M, Vandekerckhove P, Compernolle V, et al.
Curr Stem Cell Res Ther
. 2024 Dec;
20(2):218-227.
PMID: 39660501
Background: Human Platelet Lysate (hPL) is a platelet-derived and growth factor-rich supplement for cell culture. It can be prepared from surplus platelet concentrates initially intended for transfusion. Amotosalen-based photochemical pathogen...
3.
Verbrugghe C, Wouters E, Devloo R, Nurmi V, Seghers S, De Bleser D, et al.
Sci Rep
. 2024 Oct;
14(1):23579.
PMID: 39384892
We aimed to model binding of donor antibodies to virus that infects COVID-19 patients following transfusion of convalescent plasma (CCP). An immunosorbent assay was developed to determine apparent affinity (K)....
4.
Daes T, van den Hurk K, Schroyens N, Mikkelsen S, Severijns P, De Buck E, et al.
Transfus Med Rev
. 2024 Sep;
38(4):150851.
PMID: 39244430
Most plasma used for manufacturing plasma-derived medicinal products (PDMPs) such as albumin, immunoglobulin (Ig), and clotting factors is obtained from source plasma collected via plasmapheresis, the majority of which is...
5.
Van Remoortel H, Van de Sande D, Maes D, Khoudary J, Tavernier V, Tiberghien P, et al.
Vox Sang
. 2024 Sep;
119(11):1129-1140.
PMID: 39237120
Background And Objectives: Blood establishments strive to ensure the safety and comfort of blood donors while minimizing adverse events. This review aims to assess the efficacy and effectiveness of eating...
6.
Six K, Vertongen S, Seghers S, De Bleser D, Compernolle V, Feys H
J Immunol Methods
. 2024 Aug;
533:113733.
PMID: 39098592
In Flanders, an estimated 300,000 leukoreduction filters are discarded as biological waste in the blood establishment each year. These filters are a possible source of fresh donor leukocytes for downstream...
7.
Meulenbeld A, Toivonen J, Vinkenoog M, Brits T, Swanevelder R, de Clippel D, et al.
Vox Sang
. 2024 Apr;
119(7):758-763.
PMID: 38637123
Background And Objectives: Personalized donation strategies based on haemoglobin (Hb) prediction models may reduce Hb deferrals and hence costs of donation, meanwhile improving commitment of donors. We previously found that...
8.
Mortier A, Khoudary J, van Dooslaer de Ten Ryen S, Lannoy C, Benoit N, Antoine N, et al.
Vox Sang
. 2023 Nov;
119(2):134-143.
PMID: 37997609
Background And Objectives: Most research studies on the effects of repeated plasma donation are observational with different study limitations, resulting in high uncertainty on the link between repeated plasma donation...
9.
Van Remoortel H, van den Hurk K, Compernolle V, OLeary P, Tiberghien P, Erikstrup C
Transfusion
. 2023 Nov;
63(12):2358-2361.
PMID: 37982361
No abstract available.
10.
Daes T, Van de Sande D, De Buck E, Zachee P, Compernolle V, Vandekerckhove P
Vox Sang
. 2023 Oct;
119(3):219-231.
PMID: 37889847
Background And Objectives: Although screening of donated blood for syphilis is almost universally applied, its cost-effectiveness is questioned because of the low prevalence of transfusion-transmitted syphilis and a widespread belief...